New AMA workgroup to focus on telehealth CPT coding

The American Medical Association (AMA) has announced a new workgroup charged with integrating the latest telehealth technology into the Current Procedural Terminology (CPT) code set.

The Telehealth Services Workgroup is comprised of more than 50 experts representing physicians, health professionals, telemedicine innovators and health insurers.

“The CPT code set is the foundation upon which every participant in the medical community--physicians, hospitals, allied health professionals, payers and others--can efficiently share accurate information about medical services,” said AMA President Steven J. Stack, MD. “Input from the Telehealth Services Workgroup will help the CPT code set reflect new technological and telehealth advancements available to mainstream clinical practice, and ensures the code set can fulfill its role as the health system’s common language for reporting contemporary medical procedures.”

The workgroup will provide their expertise for practical enhancements that CPT needs to reflect the coding demands of emerging telehealth services and remote patient monitoring.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.